Related Experiment Video
Updated: Dec 20, 2025

Isolation of Human Ventricular Cardiomyocytes from Vibratome-Cut Myocardial Slices
Published on: May 10, 2020
Isolation of Human Ventricular Cardiomyocytes from Vibratome-Cut Myocardial Slices
Dominik J Fiegle1, Tilmann Volk2, Thomas Seidel3
1Institute of Cellular and Molecular Physiology, Friedrich-Alexander University Erlangen-Nürnberg; dominik.fiegle@fau.de.
Insights
A new vibratome slicing and enzymatic digestion protocol efficiently isolates viable cardiac myocytes from human and animal hearts. This method significantly improves cell yield compared to traditional techniques, aiding cardiac research.
Area of Science:
- Cardiovascular Biology
- Cellular Biology
- Biomedical Engineering
Background:
- Cardiac myocyte isolation is crucial for research but challenging for human samples due to limited perfusion.
- Existing methods for human cardiomyocyte isolation yield poor cell viability and require on-site cardiac surgery.
- Translating findings from animal to human cardiac research is hampered by isolation technique disparities.
Purpose of the Study:
- To develop a reliable and efficient protocol for isolating ventricular cardiac myocytes from both human and animal myocardium.
- To overcome limitations of current methods, particularly for human tissue, enabling broader research applications.
- To enhance the yield and viability of isolated cardiomyocytes for downstream functional studies.
Main Methods:
- Myocardial tissue slices (300 µm) were generated using a vibratome to maximize surface-to-volume ratio.
- Tissue slices underwent digestion with protease and collagenase.
- Yields of viable, calcium-tolerant myocytes were quantified using flow-cytometric cell counting and compared to the tissue-chunk method.
Main Results:
- The vibratome slicing method yielded significantly higher percentages of rod-shaped cardiomyocytes from rat myocardium compared to the tissue-chunk method (41.5 ± 11.9% vs. 7.89 ± 3.6%).
- The protocol successfully translated to human myocardium (failing and non-failing), showing markedly higher yields than the tissue-chunk method (45.0 ± 15.0 vs. 6.87 ± 5.23 cells/mg).
- Viable human cardiomyocytes (9-200 cells/mg) were isolated from minimal tissue amounts (<50 mg), and cells remained viable after 36h storage in cardioplegic solution.
Conclusions:
- A vibratome-based tissue slicing and enzymatic digestion protocol provides an efficient method for isolating viable cardiac myocytes from human and animal hearts.
- This protocol overcomes limitations of traditional methods, offering improved yields and applicability to rare human myocardial specimens, even without on-site cardiac surgery.
- The method facilitates research by enabling isolation of functional cardiomyocytes from diverse cardiac tissues, supporting the translation of findings across species.
Abstract:
The isolation of ventricular cardiac myocytes from animal and human hearts is a fundamental method in cardiac research. Animal cardiomyocytes are commonly isolated by coronary perfusion with digestive enzymes. However, isolating human cardiomyocytes is challenging because human myocardial specimens usually do not allow for coronary perfusion, and alternative isolation protocols result in poor yields of viable cells. In addition, human myocardial specimens are rare and only regularly available at institutions with on-site cardiac surgery. This hampers the translation of findings from animal to human cardiomyocytes. Described here is a reliable protocol that enables efficient isolation of ventricular myocytes from human and animal myocardium. To increase the surface-to-volume ratio while minimizing cell damage, myocardial tissue slices 300 µm thick are generated from myocardial specimens with a vibratome. Tissue slices are then digested with protease and collagenase. Rat myocardium was used to establish the protocol and quantify yields of viable, calcium-tolerant myocytes by flow-cytometric cell counting. Comparison with the commonly used tissue-chunk method showed significantly higher yields of rod-shaped cardiomyocytes (41.5 ± 11.9 vs. 7.89 ± 3.6%, p < 0.05). The protocol was translated to failing and non-failing human myocardium, where yields were similar as in rat myocardium and, again, markedly higher than with the tissue-chunk method (45.0 ± 15.0 vs. 6.87 ± 5.23 cells/mg, p < 0.05). Notably, with the protocol presented it is possible to isolate reasonable numbers of viable human cardiomyocytes (9-200 cells/mg) from minimal amounts of tissue (<50 mg). Thus, the method is applicable to healthy and failing myocardium from both human and animal hearts. Furthermore, it is possible to isolate excitable and contractile myocytes from human tissue specimens stored for up to 36 h in cold cardioplegic solution, rendering the method particularly useful for laboratories at institutions without on-site cardiac surgery.

